Upstream Bio, Inc.

Stock Chart, Company Information, and Scan Results

$13.63(as of Jul 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Upstream Bio, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$13.63
Ticker SymbolUPB
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees52
CountyUSA
Market Cap$407.3M
EBIDTA-65.7M
10-Day Moving Average11.55
P/E Ratio-9.23
20-Day Moving Average11.37
Forward P/E Ratio0.00
50-Day Moving Average10.70
Earnings per Share-1.36
200-Day Moving Average13.29
Profit Margin-4,818.02%
RSI72.61
Shares Outstanding53.6M
ATR0.85
52-Week High29.46
Volume396,519
52-Week Low5.14
Most Recent Support Level10.54
Book Value445.6M
Most Recent Resistance Level12.10
P/B Ratio1.64
Upper Keltner13.28
P/S Ratio318.30
Lower Keltner9.46
Debt-to-Equity Ratio13.28
Next Earnings Date08/05/2025
Cash Surplus61.7M
Next Ex-Dividend DateUnknown

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.

Upstream Bio, Inc. In Our Stock Scanner

As of Jul 25, 2025
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.